Time heals.

Risk of natural killer/T-cell lymphoma recurrence. This impressively large Chinese population-based study demonstrates that, once patients reach 3 years out from radiation treatment for early-stage NKTCL, they have a <5% annual chance of subsequent failure. | Liu, JAMA Netw Open 2019